Literature DB >> 17098674

Anaplastic thyroid cancer with uncommon long-term survival.

Ai-Hung Liu1, Li-Ying Juan, An-Hang Yang, Harn-Shen Chen, Hong-Da Lin.   

Abstract

In general, most thyroid cancers are indolent and have a slowly progressive course. The exception is anaplastic thyroid cancer. It is one of the most fatal neoplasms in humans, with median survival of 4-12 months. Here, we present a patient with anaplastic thyroid cancer who survived for more than 10 years after diagnosis. A 68-year-old man was incidentally found to have anaplastic thyroid cancer during operation for follicular neoplasm. Total thyroidectomy was performed and hyperfractionated radiotherapy was carried out. After operation, annual follow-up examinations were negative for residual tumor or metastatic lesions. The patient also had chronic obstructive pulmonary disease and unfortunately died of pneumonia in a local hospital 10 years after thyroid operation.

Entities:  

Mesh:

Year:  2006        PMID: 17098674     DOI: 10.1016/S1726-4901(09)70314-4

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

1.  Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.

Authors:  Xiaoguang Shi; Rengyun Liu; Shen Qu; Guangwu Zhu; Justin Bishop; Xiaoli Liu; Hui Sun; Zhongyan Shan; Enhua Wang; Yahong Luo; Xianghong Yang; Jiajun Zhao; Jianling Du; Adel K El-Naggar; Weiping Teng; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-01-13       Impact factor: 5.958

2.  A large nonmetastatic anaplastic thyroid cancer with complete thyroidal confinement.

Authors:  Jeffrey C Xing; Justin A Bishop; Nestoras Mathioudakis; Nishant Agrawal; Ralph P Tufano
Journal:  Case Rep Med       Date:  2011-09-07

Review 3.  Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature.

Authors:  Aurora Mirabile; Matteo Biafora; Leone Giordano; Gianluigi Arrigoni; Maria Giulia Cangi; Italo Dell'Oca; Francesca Lira Luce; Davide Di Santo; Andrea Galli; Michele Tulli; Renata Mellone; Davide Valsecchi; Vanesa Gregorc; Mario Bussi
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.